Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma
Clinical trial NCT02221492 · COMPLETED
Trial details
- NCT number
- NCT02221492
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.